The Chase Group is proud to partner with Eisai and support their human health care mission by securing a strong and agile leader for their Global Oncology Business Unit. The new Senior Medical Director is driving the medical affairs portfolio and team for the Women’s Cancer Care, Oncology Business Unit. Drawn to Eisai’s patient-focused business mindset, this new medical lead has hit the ground running, contributing to finding innovative solutions in disease prevention, treatment, and care for the health and wellbeing of people worldwide. To learn more about how The Chase Group can help you secure high caliber executive talent, please contact Moira Newbanks at moira@chasegroup.com for more information.
Partnership with The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit
The Chase Group is proud to partner with Eisai and support their human health care mission by securing a strong and agile leader for their Global Oncology Business Unit. The new Senior Medical Director is driving the medical affairs portfolio and team for the Women’s Cancer Care, Oncology Business Unit. Drawn to Eisai’s patient-focused business mindset, this new medical lead has hit the ground running, contributing to finding innovative solutions in disease prevention, treatment, and care for the health and wellbeing of people worldwide. To learn more about how The Chase Group can help you secure high caliber executive talent, please contact Moira Newbanks at moira@chasegroup.com for more information.- Categories: Life Sciences, Pharmaceutical
Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership with The Chase Group
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually…
The Chase Group Continues Successful Collaboration with Genmab Through Placement of Vice President, CDTL
The Chase Group, known for its thorough search capabilities and expertise in Life Sciences Executive Search, was retained by Genmab Pharmaceuticals to execute a critical…
The Chase Group Successfully Secures Vice President, Head of Medical Development for Checkmate Pharmaceuticals
Building on a 14+ year relationship with Chase, the Chief Medical Officer of Checkmate Pharmaceuticals retained The Chase Group to identify a critical hire for…
Search Executed by The Chase Group, Inc. Results in Successful Appointment of Dr. Christophe Hotermans as SVP, Global Medical Affairs for Akcea Therapeutics
The Chase Group was once again retained by Akcea Therapeutics to complete an extensive executive search on an accelerated timeline for a Senior Vice President,…-
Appointment of William Andrews, M.D. as Chief Medical Officer at Akcea Therapeutics Successfully Completed by The Chase Group
The Chase Group, known for relationship building with proven success in life sciences executive search, was retained by Akcea Therapeutics, to identify and secure a… 
Biologics Consulting Leadership Team Grows Through Partnership with The Chase Group
Through focused collaboration with The Chase Group, Biologics Consulting has entered a season of growth by successfully placing, in a newly created position, a Director,…